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Abstract
Background/Aims: Although some evidence suggests that the prevalence of osteoarthritis 
(OA) is lower in smokers compared to nonsmokers, the mechanisms of nicotine-induced 
protection remain unclear. Stimulation of the α7 nicotinic acetylcholine receptor (α7-nAChR) 
appears to be a critical mechanism underlying the anti-inflammatory potential of cholinergic 
agonists in immune cells. The inhibition of secreted inflammatory molecules and the subsequent 
inflammatory processes have been proposed as a novel strategy for the treatment of OA. The 
objective of the present study was to determine whether nicotine-induced protection in a 
monosodium iodoacetate (MIA) rat model of OA occurs via α7-nAChR-mediated inhibition 
of chondrocytes. Methods: Both in vivo (MIA) and in vitro (MIA; Interleukin-1β, IL-1β) 
models of OA were used to investigate the roles and the possible mechanisms whereby α7-
nAChRs protect against knee joint degradation. Multiple experimental approaches, including 
macroscopic, histological analysis, chondrocyte cell cultures, confocal microscopy, and western 
blotting, were employed to elucidate the mechanisms of α7-nAChR-mediated protection. 
Results: Systemic administration of nicotine alleviated MIA-induced joint degradation. The 
protective effects of nicotine were abolished by administration of the α7-nAChR-selective 
antagonist methyllycaconitine (MLA). In primary cultured rat chondrocytes, pretreatment with 
nicotine suppressed both p38, extracellular regulated kinase (Erk) 1/2 and c-Jun-N-terminal 
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kinase (JNK) mitogen-activated protein kinases (MAPK) phosphorylation and phosphorylated 
nuclear factor-kappa B (NF-kB) p65 activation induced by MIA- or IL-1β, and these effects 
were also reversed by MLA. Conclusion: Taken together, our results suggest that activation 
α7-nAChRs is an important mechanism underlying the protective effects of nicotine. 
IntroductionOsteoarthritis (OA), the most common type of arthritis affecting the elderly [1], dramatically impacts health care because of its negative effect on mobility. The extent 
of articular inflammation is normally associated with disease progression, pointing to articular damage as a contributor to this disease [2]. Recent evidence from both in vitro and in vivo studies suggests that chondrocytes can release and respond to a number of different cytokines, and are key active players during the disease process [3-5]. Interleukin 
(IL)-1β and tumor necrosis factor (TNF)-α are the foremost cytokines involved in the 
physiopathology of OA [6]. Consequently, drugs that inhibit secreted inflammatory molecules, 
such as proinflammatory cytokines, and their ensuing inflammatory induction, may provide 
understanding into enduring pathogenic injuries, and identifying molecular targets for new therapeutic interventions in OA. 
There is increasing evidence that nicotine employs anti-inflammatory and immuno-modulatory effects on many cell types, such as T cells, B cells, dendritic cells, astrocytes and polymorphonuclear leukocytes, in the lung, spleen, liver, joints and the gastrointestinal tract 
[7]. The vagus nerve can modify immune responses and influence inflammation through an alpha7-nicotinic acetylcholine receptor (α7-nAChR) dependent anti-inflammatory pathway [8]. Yu et al. reported that nicotine-induced modulation of adjuvant-induced arthritis 
(AIA) involves specific alterations in the disease-related cellular and humoral immune 
responses in AIA [9]. α7-nAChR knockout mice showed significant increases in both the 
incidence and severity of arthritis, and synovial inflammation as well as joint destruction 
were also demonstrated in murine collagen-induced arthritis (CIA) [10, 11]. Evidence of the 
cholinergic anti-inflammatory pathway in the murine CIA model of rheumatoid arthritis or 
other arthritis models has been established, however, little is known about the role of α7-
nAChRs in regulating pro-inflammatory cytokines in the pathophysiology of OA. By injecting monosodium iodoacetate (MIA), a glyceraldehyde-3-phosphate dehydrogenase activity inhibitor, into a joint, one can rapidly induce OA-like lesions in both 
rodent and nonrodent models [12-15]. In rodents, this model yields cartilage lesions with loss of proteoglycan matrix and functional joint impairment much like human OA [16, 17]. 
Here, the main objective was the determination, using in vivo and in vitro models, of 
nicotine, acting on the α7-nAChRs, as an inhibitor of chondrocyte-mediated inflammation triggered by MIA, and potentially a cartilage degeneration preventer. This possible anti-
inflammatory mechanism, induced by nicotine, was further investigated using IL-1β, the 
main proinflammatory cytokine involved in the pathophysiology of OA [6]. Moreover, we 
investigated whether α7-nAChR function is associated with modulation of phosphorylation of the mitogen-activated protein kinases (MAPKs) and members of the nuclear factor-kappa 
B (NF-kB) pathway. 
Materials and Methods 
Animals and treatments 
All experiments were carried out in accordance with the guidelines of the National Institutes of Health for the Care and Use of Laboratory Animals (publication number 85–23, revised 1985) and the Society for 
Neuroscience Guidelines for the Care and Use of Animals in Neuroscience Research, and were approved by 
the Institutional Animal Care and Use Committee of Nanjing Medical University [18]. 
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Male Sprague-Dawley rats (2 months old, 175 to 200 g in weight) were used. All animals were housed 
in groups of five per cage under standard laboratory conditions with free access to food and water, constant 
room temperature (22°C) and humidity (50% to 60%), and a natural day/night cycle. 
Nicotine, methyllycaconitine citrate (MLA), and MIA were dissolved in sterile saline (0.9% NaCl). Rats 
were randomly divided into groups as described below. All drugs were acquired from Sigma Chemical Co. (St. Louis, MO, USA). 
The chronic MIA induction protocol was similar to that described previously [19]: 1 mg of MIA in 
50 µL of sterile physiologic saline solution was injected once a week for 4 weeks into the right knees 
through the infrapatellar ligament. Rats were euthanized 1 week after final injection. Vehicle control rats 
were treated with saline. During nicotine treatment, rats were given intraperitoneal injections of nicotine 
1 mg/kg once per day for 5 weeks (1 week before and throughout MIA administration). For all nicotine 
antagonism experiments MLA 1 mg/kg was injected 30 min before nicotine administration.
Macroscopic analysis 
Macroscopic lesions were graded as follows: 0 = normal appearance; 1 = slight yellowish discoloration 
of the chondral surface; 2 = small cartilage erosions in load-bearing areas; 3 = large erosions extending 
down to the subchondral bone; and 4 = large erosions with large areas of subchondral bone exposure. Each of the chondral compartments of the knee (the femoral condyles, the tibial plateaus, the patella, and the 
femoral groove) was graded by two segregated observers who were blinded to the induction procedure. 
The four compartmental scores were combined (for a maximum possible score of 16) and the mean was 
determined for each group [20].   
Histological analysis 
Whole knee joints were fixed immediately in 4% paraformaldehyde, decalcified, and embedded in 
paraffin. Sagittal sections were stained with hematoxylin (HES) and toluidine blue. The severity of the OA 
lesions was graded according to Mankin’s score [21] with minor modifications. This scale evaluates the 
severity of OA lesions based on proteoglycan integrity (scale 0–4), cellular changes (scale 0–3), collagen 
fiber integrity (scale 0–3), invasion of the tidemark by blood vessels (scale 0–1), bone modifications (scale 
0–2) and structural changes (scale 0–5, where 0 = normal cartilage structure and 5 = erosion of the cartilage 
down to the subchondral bone) [22]. 
Chondrocyte cultures 
Normal articular cartilage was obtained from Sprague-Dawley rats euthanized under anesthesia. After 
joint surgery, articular cartilage pieces were aseptically dissected from femoral head caps and chondrocytes 
were obtained by sequential digestion with pronase (2 mg/mL) and collagenase B (1.5 mg/mL) (Roche, 
Basel, Switzerland). The cells were washed twice in phosphate-buffered saline (PBS) and cultured to 
confluence in 75 mm2 flasks at 37°C in a humidified atmosphere containing 5% CO2. The medium used 
was DMEM/Ham's F-12 supplemented with L-glutamine (2 mM), gentamicin (50 µg/mL), amphotericin B 
(0.5 g/mL), and heat-inactivated fetal calf serum (FCS, 10%). Chondrocytes were cultured under low FCS 
conditions (10%, v/v) and used at confluence [22]. 
Staining with α-bungarotoxin and confocal microscopy
Primary cultured chondrocytes (as described above) were passaged into six-well tissue-culture plates 
at 5 × 105 cells per well, and then cultured for 24 h. Thereafter, cultures were incubated with Alexa Fluor 
488-conjugated α-bungarotoxin (2.5 μg/mL; B13422, Invitrogen Corp., Carlsbad, CA) at 4°C for 15 min. 
Immediately after incubation, these cells were washed with PBS three times, and then fixed for 15 min in 
4% paraformaldehyde in PBS at room temperature. After fixation, cells were washed once with PBS and then 
mounted for viewing under a laser scanning confocal microscope (Meta 710 Laser Scanning Microscope, 
Carl Zeiss Inc., Thornwood, NY) [18]. 
Western blotting
Cells were collected and homogenized in 200 μL lysis buffer. After incubation for 20 min on ice, cell 
lysates were separated by centrifugation, and the protein concentration in the extracts was determined by 
the Bradford assay. Proteins in the cell extracts were denatured with SDS sample buffer and separated by 10% 
SDS-PAGE. Proteins were transferred to nitrocellulose membranes using a wet transfer unit (Miniprotean®-
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III; Bio-Rad Laboratories, Inc., Hercules, CA). The membranes were then incubated with 5% BSA dissolved 
in Tris-buffered saline with Tween 20 (TBS-T, 10 mmol/L Tris–HCl, 150 mmol/L NaCl, and 0.1% Tween 20, 
pH 7.5) at room temperature for 1 h, washed three times, and incubated with different antibodies (p38, 
phospho-p38, extracellular regulated kinase1/2 [Erk1/2], phosphor-Erk1/2, the c-Jun-N-terminal kinase 
[JNK], phosphor-JNK and phosphor-NF-kB p65, 1:1000; Cell Signaling Technology Inc., Beverly, MA; α7-
nAChRs, 1:300, Santa Cruz Biotechnology Inc., Santa Cruz, CA) overnight at 4°C. The following day the 
membranes were washed three times with TBS-T buffer, and incubated with secondary antibody for 1 h, 
followed by four washes in TBS-T. Signal detection was performed with an enhanced chemiluminescence kit. 
The results were scanned using a gel imaging system (GelMax Imager; Ultra-Violet Products Ltd., Upland, 
CA) and measured using analyzing software (GelPro Analyzer software; Media Cybernetics, Inc., Bethesda, MD) [18]. 
Statistical analyses All values are expressed as mean ± standard error of the mean (SEM). Differences between means 
were analyzed using one-way or two-way analysis of variance (ANOVA) with time and treatment as the 
independent factors. When ANOVA showed significant differences, pairwise comparisons between means 
were further analyzed using the Newman-Keuls post hoc test. In all analyses, significance was set at P = 0.05 [18]. 
Results 
Nicotine acting via α7-nAChRs prevents MIA-induced cartilage degradation in rats. To examine the effects of nicotine on cartilage degradation in rats, macroscopic and 
Mankin’s scores of the knee joints acquired at the conclusion of the experiment were assessed. Intra-articular injection of 1 mg of MIA induced knee joint deterioration, as evidenced by the 
cartilage on the central load-bearing areas of each articular surface was thin and yellowish, 
with focal erosions of the femoral condyles and tibial plateaus, as can be observed from 
the macroscopic score (Fig. 1A) [11, 23]. HES and toluidine blue staining revealed major remodeling of subchondral bone, loss of the hypertrophic chondrocyte layer and a decrease 
in cellularity in the MIA group (Fig. 1B, C). Nicotine (1 mg/kg) suppressed increases in MIA-
induced macroscopic and Mankin’s scores (P < 0.01) compared with MIA treatment alone. Interestingly, the protective effect of nicotine against MIA-induced cartilage degradation 
was reversed by pretreatment with MLA (1 mg/kg) (Fig. 1D, E) (P < 0.01). Notably, there 
were significant differences between the control group and the experimental group treated 
with both MIA and nicotine (P < 0.05), implying that although MLA could entirely invert the protective effect of nicotine against MIA-induced cartilage degradation, nicotine cannot fully 
prevent the MIA-induced cartilage degradation effects. No significant cartilage degradation 
changes were seen in mice treated with nicotine and MLA alone (P>0.05 compared with 
controls, data not shown). 
Expression of the α7-nAChR subunit in chondrocytes 
To further examine the hypothesis that nicotine-induced cartilage fortification in an MIA 
rat model is mediated through its actions on α7-nAChRs on chondrocytes, the expression 
of α7-nAChRs was evaluated using primary cultured chondrocytes. The α7-nAChR subunit 
protein was identified by western blotting in primary cultured cells (Fig. 2A). Furthermore, 
to evaluate whether α-bungarotoxin, an α7-nAChR subunit-selective blocker, could bind 
to this receptor, primary chondrocytes were stained with Alexa Fluor 488 conjugated 
α-bungarotoxin. Strong binding of α-bungarotoxin was detected on the chondrocyte surface 
(Fig. 2B). 
Nicotine acting via α7-nAChRs suppresses p38, Erk1/2 and JNK MAPK activation induced 
by MIA in chondrocytes MAPKs collectively constitute crucial signaling molecules in the development of 
inflammation. Phosphorylation of MAPKs leads to the commencement of signal cascades 
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that controls the creation of a variety of pro-inflammatory factors such as TNF-α in 
chondrocytes [24-26]. In the current study, we considered whether nicotine abolished 
the MIA-induced phosphorylation of p38, Erk1/2 and JNK MAPKs in chondrocytes. MIA 
treatment (10 μmol/L) induced rapid and transient phosphorylation of p38, Erk1/2 and 
JNK, reflecting their activation, and peak levels of phosphorylated p38, Erk1/2 and JNK 
occurred after 2 h (Fig. 3A, B, C). These outcomes imply that p38, Erk1/2 and JNK MAPKs are 
activated in response to MIA stimulation in chondrocytes. Then, we investigated the effects 
of nicotine on MIA-induced p38, Erk1/2 and JNK MAPK phosphorylation. Pretreatment 
with 10 μmol/L nicotine attenuated MIA-induced increases of phosphorylated p38, Erk1/2 
Fig. 1. Evaluation of ni-cotine-mediated protec-tion against MIA-induced knee joint degradation by macroscopic and histologi-cal analysis. (A) Represen-tative macroscopic photo-graphs of tibial plateaus of the rat knee joints. (B) Pho-
tomicrographs showing representative hematoxy-lin staining of the rat knee joints. (C) Photomicrogra-
phs showing representati-ve toluidine blue staining of the rat knee joints. (D) Semiquantitative macros-copic scores for joint des-
truction. (E) Semiquanti-
tative Mankin’s score for joint destruction. Data are 
presented as mean ± SEM 
(n = 6). *P < 0.05 and **P < 
0.01 vs. the control (saline 
alone) group; ##P < 0.01 vs. the MIA treatment group. ※※P < 0.01 between the MIA + nicotine treatment 
group and the MIA + nicotine + MLA treatment group. Scale bar: 200 μm. 
Fig. 2. nAChR α7 subunit expression in primary chondrocyte cell cultures. (A) Western blot of α7 nAChR 
protein in primary cultured chondrocytes. (B) Primary rat chondrocytes were stained with Alexa Fluor 488 
conjugated α-bungarotoxin and viewed by fluorescent confocal microscopy. Scale bar: 20 μm. 
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and JNK (Fig. 3D, E, F). Furthermore, the attenuating effects of nicotine on p38, Erk1/2 
and JNK phosphorylation were completely blocked by 30 min of pretreatment with MLA 
at 10 nmol/L. No significant changes of phosphorylated p38, Erk1/2 and JNK were seen in 
chondrocytes treated with nicotine and MLA alone (P>0.05 compared with controls, data 
not shown). Collectively, These data infer that nicotine, acting on the α7-nAChRs, suppresses 
MAPK signal transduction, thereby influencing inflammation systems. 
Nicotine acting via α7-nAChRs suppresses p38, Erk1/2 and JNK MAPK activation induced 
by IL-1β in chondrocytes 
Amongst the proinflammatory cytokines implicated in OA, IL 1β is believed to be the foremost in cartilage degradation [6]. We explored the possibility that nicotine also 
regulated IL 1β-induced MAPK signaling transduction. Chondrocytes were treated with IL 1β 
at 10 ng/mL for different lengths of time to determine the extent of MAPK activation after 
IL 1β stimulation. Treatment with IL 1β also resulted in rapid and transient phosphorylation 
of p38, Erk1/2 and JNK, with peak levels also occurring at 30 min (Fig. 4A, B, C). These 
results suggest that p38, Erk1/2 and JNK are triggered in reaction to IL 1β stimulation in 
chondrocytes. We then investigated whether nicotine could regulate IL 1β-induced p38, 
Erk1/2 and JNK phosphorylation. Pretreatment with nicotine at 10 μmol/L suppressed IL-
1β-induced increases in phosphorylated p38, Erk1/2 and JNK (Fig. 4D, E, F). Additionally, 
the suppressive effects of nicotine on p38, Erk1/2 and JNK phosphorylation were entirely 
reversed by MLA (10 nmol/L). These data suggest that nicotine, through its actions on α7-
nAChRs, also inhibits IL 1β-induced chondrocyte activation via inhibition of MAPK signal transduction. 
Fig. 3. The effects of nicotine on 
MIA-induced p38, Erk1/2 and JNK MAPK activation in chondrocytes. 
MIA increased p38, Erk1/2 and JNK MAPK phosphorylation, indicative of their activation. (A,B,C) Chondrocy-
tes were treated with 10 μM MIA for various lengths of time as indicated. 
(D,E,F) Chondrocytes were pretrea-
ted with nicotine (10 μM) in the ab-
sence or presence of MLA (10 nM) 
for 30 min and then challenged with 
MIA (10 μM) for 30 min. After treat-
ment, chondrocytes were harvested and levels of phosphorylated p38 (D), 
Erk1/2 (E) and JNK (F) MAPKs were 
analyzed. Lower: representative blots 
are shown. Upper: densitometric ana-lysis of the phosphorylated forms of 
p38, Erk1/2 and JNK MAPK. Data are 
presented as the mean ± SEM of four 
independent experiments. *P < 0.05 
and **P < 0.01 vs. the control (saline 
alone) group; ##P < 0.01 vs. the MIA treatment group. ※※P < 0.01 between 
the MIA + nicotine treatment group 
and the MIA + nicotine + MLA treat-ment group.
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Nicotine or MLA administration alone did not significantly affect p38, Erk1/2 and JNK 
phosphorylation in chondrocytes (P>0.05 compared with controls, data not shown). 
Nicotine acting via α7-nAChRs suppresses MIA or IL-1β-induced phospho-NF-kB p65 
activation in chondrocytes 
To further examine the mechanisms of nicotine-mediated suppression of inflammatory 
responses in MIA or IL 1β-activated chondrocytes, we focused on the activation of NF-kB, a 
family of transcription factors related to inflammatory responses and cartilage degradation. 
The results suggest that treatment with MIA at 10 μmol/L or IL-1β at 10 ng/mL induced 
phosphorylation of NF-κB p65 (Fig. 5A, B). These results suggest that NF-κB is activated 
in response to MIA or IL-1β stimulation in chondrocytes. Pretreatment with nicotine at 10 
μmol/L suppressed IL-1β- or MIA-induced increases in phosphorylated NF-κB p65, and these 
effects could be prevented by 10 nmol/L MLA (Fig. 5C, D). Nicotine or MLA administration 
alone did not significantly affect NF-κB p65 phosphorylation in chondrocytes (P>0.05 
compared with controls, data not shown). This data point to nicotine acting, via α7-nAChRs, 
dampens phosphorylation of NF-κB p65. 
Discussion
Both the initiation and advancement of OA are now thought to include inflammation 
even in the preliminary stages of the disease [27]. Several studies show a distinct connection 
Fig. 4. The effects of nicotine on 
IL 1β-induced p38, Erk1/2 and JNK MAPK activation in chondrocytes. 
IL 1β also increased p38, Erk1/2 
and JNK MAPK phosphorylation, 
reflecting their activation. (A,B,C) 
Chondrocytes were treated with 
10 ng/mL IL 1β for various lengths 
of time as indicated. (D,E,F) 
Chondrocytes were pretreated 
with nicotine (10 μM) in the absen-
ce or presence of MLA (10 nM) for 
30 min and then challenged with 
IL 1β (10 ng/mL) for 30 min. After 
treatment, chondrocytes were har-vested and levels of phosphoryla-
ted p38 (D), Erk1/2 (E) and JNK 
(F) MAPKs were analyzed. Lower: 
representative blots are shown. 
Upper: densitometric analysis of the phosphorylated forms of p38, 
Erk1/2 and JNK MAPK. Data are 
presented as the mean ± SEM of 
four independent experiments. *P 
< 0.05 and **P < 0.01 vs. the cont-
rol (saline alone) group; #P < 0.05 
and ##P < 0.01 vs. the IL 1β treat-ment group. ※P < 0.05 and ※※P < 
0.01 between the IL 1β + nicotine 
treatment group and the IL 1β + ni-
cotine + MLA treatment group.
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between the evolution of tibiofemoral cartilage damage and the occurrence of activated 
synovial macrophages [28, 29]. Discharged inflammatory factors such as proinflammatory cytokines are essential mediators of the disturbed metabolism and enhanced catabolism of joint tissue involved in OA [6]. Consequently, drugs that can inhibit the performance of 
secreted inflammatory molecules, such as proinflammatory cytokines, and the ensuing 
inflammatory progression may contribute to articular fortification. 
During this investigation, we found that systemic administration of nicotine significantly 
improved MIA-induced cartilage degradation assessed by macroscopic and Mankin’s score 
of knee joints. Additionally, we discovered that nicotine inhibited MIA- or IL 1β-stimulated 
elevation of phosphorylation of p38, Erk1/2 and JNK MAPKs and of NF-κB p65 from reactive 
chondrocytes. The p38, Erk1/2 and JNK MAPKs signaling pathways are essential in cartilage 
depletion [30]. Sondergaard et al. found that inhibition of the MAPK p38, p44/42 and Src family abolished proteolytic cartilage degradation by blocking MMP synthesis and activity 
[31]. Moreover, growing evidence demonstrates that NF-κB signaling as not only playing 
a key role in the pro-inflammatory stress-related responses of chondrocytes to extra- and intra-cellular insults, but also in the management of their differentiation program [32]. 
Martel-Pelletier et al. found that MAPKs and NF-κB together regulate interleukin-17-induced nitric oxide production in human osteoarthritic chondrocytes [33]. Taken together, our data 
indicate that the p38, Erk1/2 and JNK MAPKs and NF-κB signaling-transduction pathways 
are involved in the inhibitory effects of nicotine on MIA- or IL 1β-induced chondrocyte activation. 
The Framingham study was one of the first to generate the hypothesis that smoking 
may protect against OA. The negative association was identified in both cross-sectional [34] 
and cohort analyses [35]. This supposition is also well advocated by several epidemiological 
reports [36-40], which have reported that the frequency of OA is lower in smokers than in 
Fig. 5. The effects of ni-
cotine on MIA- or IL 1β--
induced NF-κB p65 activa-tion in chondrocytes. (A,B) 
Chondrocytes were treated 
with 10 μM MIA or 10 ng/
mL IL 1β for various lengths of time as indicated. (C,D) 
Chondrocytes were pretre-
ated with nicotine (10 μM) in the absence or presence 
of MLA (10 nM) for 30 min 
and then challenged with 
MIA (10 μM) or IL 1β (10 
ng/mL) for 30 min. After treatment, chondrocytes 
were harvested and levels 
of phosphorylated NF-kB 
p65 were analyzed. Lower: representative blots are 
shown. Upper: densitomet-ric analysis of the phospho-
rylated forms of NF-kB p65. Data are presented as the mean ± SEM of four independent experiments. *P < 
0.05 and **P < 0.01 vs. the control (saline alone) group; #P < 0.05 and ##P < 0.01 vs. the IL 1β treatment group. ※P < 0.05 and ※※P < 0.01 between the IL 1β + nicotine treatment group and the IL 1β + nicotine + MLA treatment group.
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nonsmokers, leading to the hypothesis that the reduced occurrence of OA in smokers may be due to the presence of nicotine from tobacco. Considerable evidence supports that nicotine 
exerts its effects primarily by acting on nAChRs [41]. These subunits combine in the formation 
of a large family of nAChRs, the most abundant of which are heteromeric β2-containing nAChRs and homomeric α7 nAChRs. Recent studies suggest that the role of α7-nAChRs in 
immune responses and inflammatory cascades has attracted much interest according to their apparent relevance to a variety of human diseases, such as diabetes, asthma, cystic 
fibrosis, Parkinson’s disease, sepsis, ulcerative colitis and arthritis. Those diseases have 
been related to runaway cytokine-mediated inflammation [42]. Cytokine-based therapeutic 
agents play a major role in the treatment of these diseases. The ‘nicotinic anti-inflammatory 
pathway’ may have critical clinical implications, as treatment with nicotinic agonists can 
potentially moderate the production of pro-inflammatory cytokines from immune cells via 
α7 homomeric nAChRs (α7-nAChRs) [43, 44]. 
In the current study, we found that the alleviation of MIA-induced cartilage degradation 
in the knee was reversed by the α7-nAChR-selective antagonist MLA. In rat primary cultured 
chondrocytes, pretreatment with nicotine suppressed MIA- or IL 1β-induced chondrocyte 
activation, as shown by inhibition of phosphorylation of p38, Erk1/2 and JNK MAPKs 
and NF-κB p65. These inhibitory effects of nicotine were also reversed by MLA. Those data demonstrated that nicotine-induced protection in a MIA rat model of OA occurs via 
α7-nAChR-mediated inhibition of chondrocytes. It is of interest to explore the possible 
mechanisms by which α7-nAChRs could trigger responses in different cells. At first, it was 
thought that the cell response was mediated by influx of calcium through activated nAChRs, causing an increase in the intracellular calcium concentration, and then activated variety 
signaling cascade. Moreover, α7-nAChR agonists also can modulate several other signaling 
pathways such as Jak2/STAT3 signaling pathway [45]. Together with results from various other studies, these data suggest that additional and yet not fully clear mechanisms to link 
ligand gated ion channels to intracellular signaling pathways might exist [41]. 
However, nicotine might also play a much more direct part in this process. Data from a 
previous study showed that nicotine upregulates glycosaminoglycan and collagen synthesis 
by articular chondrocytes at physiological levels seen in those who smoke [46]. Ying et al. reported that nicotine promoted proliferation and collagen synthesis of chondrocytes 
isolated from normal human and OA patients [47]. The exact mechanism underlying the 
protection provided by nicotine must still be fully characterized. 
Our results are the first to demonstrate that nicotine inhibits MIA-induced (in vivo) 
and MIA- or IL 1β-induced (in vitro) chondrocyte activation via α7-nAChRs and decreases 
the resulting phosphorylation of p38, Erk1/2 and JNK MAPKs and NF-κB p65. These data strongly support the hypothesis that inhibition of chondrocyte activation by stimulation of 
α7-nAChRs may provide a new therapeutic strategy for treatment of inflammation-related 
disorders. Thus, nicotinic agonists that specifically target the α7-nAChR might serve as 
potential therapeutic agents for OA and other inflammation-related diseases. 
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